Annals of Emergency Medicine
Volume 37, Issue 2 , Pages 196-201, February 2001

Recurrence phenomena after immunoglobulin therapy for snake envenomations: part 2. Guidelines for clinical management with crotaline fab antivenom☆☆☆

Presented at the North American Congress of Clinical Toxicology’s “Advances in the Management of Snakebite” Symposium, October 1999, La Jolla, CA.

  • Leslie V. Boyer, MD

      Affiliations

    • Department of Pediatrics
    • Department of Pediatrics
    • Arizona Poison and Drug Information Center
    • ,
  • Steven A. Seifert, MD

      Affiliations

    • Arizona Poison and Drug Information Center
    • ,
  • Jeffrey S. Cain, MD

      Affiliations

    • University of Arizona Health Sciences Center, Tucson, AZ; and Darnall Army Community Hospital, Ft. Hood, TX.

Received 20 October 1999; received in revised form 11 September 2000 and 1 November 2000; accepted 1 December 2000.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Supported in part by Altana, Inc.

☆☆ Address for reprints: Leslie Boyer, MD, Arizona Poison and Drug Information Center, 1501 North Campbell Avenue, Tucson, AZ 85724; 520-626-6229, fax 520-626-2720;,E-mail boyer@pharmacy.arizona.edu .

PII: S0196-0644(01)75897-0

doi:10.1067/mem.2001.113134

Refers to article:

  • Out-of-hospital and interhospital management of crotaline snakebite

    Patrick E. McKinney
    Annals of Emergency Medicine February 2001 (Vol. 37, Issue 2, Pages 168-174)

  • Role of surgical intervention in the management of crotaline snake envenomation

    Edward L. Hall
    Annals of Emergency Medicine February 2001 (Vol. 37, Issue 2, Pages 175-180)

  • Efficacy, safety, and use of snake antivenoms in the United States

    Richard C. Dart, Jude McNally
    Annals of Emergency Medicine February 2001 (Vol. 37, Issue 2, Pages 181-188)

  • Recurrence phenomena after immunoglobulin therapy for snake envenomations: part 1. Pharmacokinetics and pharmacodynamics of immunoglobulin antivenoms and related antibodies

    Steven A. Seifert, Leslie V. Boyer
    Annals of Emergency Medicine February 2001 (Vol. 37, Issue 2, Pages 189-195)

Annals of Emergency Medicine
Volume 37, Issue 2 , Pages 196-201, February 2001

Article Tools

* Image Usage & Resolution